Zein Youssef El's Form 4 filing
Aceragen, Inc. (ACGN) · filed Jul 19, 2023
- Accession no.
- 0000899243-23-017446
- Filed
- Jul 19, 2023, 4:05 PM ET
- Trade date
- May 17, 2023
- Filing delay
- 63 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $38.3K. It was filed 63 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zein Youssef ElCIK 0001193366 | 10% Owner |
| Pillar Invest CorpCIK 0001534428 | 10% Owner |
| Umari AbudeCIK 0001783582 | 10% Owner |
| Pillar Partners Foundation, L.P.CIK 0001783583 | 10% Owner |
| Pillar Pharmaceuticals 6, L.P.CIK 0001783584 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 17, 2023 | Common Stock | PPurchaseAcquired | +26,965 | $1.42 | +$38,290.3 | 170,712 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.